These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29184533)

  • 1. Correlations between Motor Symptoms across Different Motor Tasks, Quantified
    Kuhner A; Schubert T; Cenciarini M; Wiesmeier IK; Coenen VA; Burgard W; Weiller C; Maurer C
    Front Neurol; 2017; 8():607. PubMed ID: 29184533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motion Biomarkers Showing Maximum Contrast Between Healthy Subjects and Parkinson's Disease Patients Treated With Deep Brain Stimulation of the Subthalamic Nucleus. A Pilot Study.
    Kuhner A; Wiesmeier IK; Cenciarini M; Maier TL; Kammermeier S; Coenen VA; Burgard W; Maurer C
    Front Neurosci; 2019; 13():1450. PubMed ID: 32116488
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-Dimensional, Short-Timescale Quantification of Parkinson's Disease and Essential Tremor Motor Dysfunction.
    Sanderson JB; Yu JH; Liu DD; Amaya D; Lauro PM; D'Abreu A; Akbar U; Lee S; Asaad WF
    Front Neurol; 2020; 11():886. PubMed ID: 33071924
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Effects of Subthalamic Deep Brain Stimulation on Motor Outcomes in Parkinson's Disease; 13 Year Follow Up.
    Zhou H; Wang L; Zhang C; Qiu X; Hu W; van der Stelt O; Ramirez-Zamora A; Li D
    Front Neurol; 2019; 10():689. PubMed ID: 31293511
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease.
    Israeli-Korn SD; Hocherman S; Hassin-Baer S; Cohen OS; Inzelberg R
    PLoS One; 2013; 8(6):e65270. PubMed ID: 23776460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation challenge test after STN DBS improves satisfaction in Parkinson's disease patients.
    Geraedts VJ; van Hilten JJ; Marinus J; Mosch A; Naarding KJ; Hoffmann CFE; van der Gaag NA; Contarino MF
    Parkinsonism Relat Disord; 2019 Dec; 69():30-33. PubMed ID: 31665685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Step Angle for Quantifying the Gait Impairment of Parkinson's Disease by Wearable Sensors: Controlled Study.
    Wang J; Gong D; Luo H; Zhang W; Zhang L; Zhang H; Zhou J; Wang S
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e16650. PubMed ID: 32196458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum.
    Artusi CA; Romagnolo A; Imbalzano G; Montanaro E; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2021 May; 86():5-9. PubMed ID: 33812276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinematic Metrics from a Wireless Stylus Quantify Tremor and Bradykinesia in Parkinson's Disease.
    Maldonado-Naranjo A; Koop MM; Hogue O; Alberts J; Machado A
    Parkinsons Dis; 2019; 2019():6850478. PubMed ID: 31061696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.
    DiMarzio M; Pilitsis JG; Gee L; Peng S; Prusik J; Durphy J; Ramirez-Zamora A; Hanspal E; Molho E; McCallum SE
    Neuromodulation; 2018 Aug; 21(6):617-622. PubMed ID: 29608802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.